AaviGen
Pre-clinicalTargeting cardiac disease simply, precisely, and safely with patient tailored cutting-edge biotechnological tools.
Founded
2018
Focus
RNA & Gene Therapy
About
Targeting cardiac disease simply, precisely, and safely with patient tailored cutting-edge biotechnological tools.
Company Info
TypePrivate
Founded2018
LocationMunich, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile